Nothing!
Lantus is a long-acting basal insulin analog produced by Aventis and is the first true long-acting basal insulin. Injection once daily lasts 24 hours.
NovoRapid is a biosynthetic human insulin analog produced by Eli Lilly and Company of the United States.
Advantages of Lantus: It has good blood sugar control effect and effectively reduces fasting blood sugar and glycated hemoglobin. The incidence of hypoglycemia is low.
Disadvantages: expensive; slow-acting, not suitable for treating acute and severe diabetes.
Advantages of NovoRapid: It acts quickly, can be injected immediately before meals or after meals, the absorption is relatively stable, the action time does not exceed 4 hours, and the risk of hypoglycemia at night is small.
Lantus is mainly used to control fasting blood sugar, and NovoRapid is mainly used to reduce postprandial blood sugar. The combination of the two can well control the patient's blood sugar level and bring it up to standard!
However, it is also important to continue to monitor blood sugar and understand the impact of eating, exercise, and drugs on blood sugar so that you can adjust your insulin dosage in a timely manner!